143 related articles for article (PubMed ID: 3310004)
1. Phenotype and functional characterization of NK and LAK cells following T-depleted bone marrow transplantation.
Keever CA; Welte K; Sullivan M; O'Reilly RJ
Prog Clin Biol Res; 1987; 244():423-32. PubMed ID: 3310004
[No Abstract] [Full Text] [Related]
2. Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.
Keever CA; Welte K; Small T; Levick J; Sullivan M; Hauch M; Evans RL; O'Reilly RJ
Blood; 1987 Dec; 70(6):1893-903. PubMed ID: 3118990
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.
De Villartay JP; Le Deist F; Griscelli C; Fischer A
Clin Exp Immunol; 1987 Feb; 67(2):406-14. PubMed ID: 3301094
[TBL] [Abstract][Full Text] [Related]
4. HLA nonidentical T cell depleted marrow transplants: a comparison of results in patients treated for leukemia and severe combined immunodeficiency disease.
O'Reilly RJ; Keever C; Kernan NA; Brochstein J; Collins N; Flomenberg N; Laver J; Emanuel D; Dupont B; Cunningham I
Transplant Proc; 1987 Dec; 19(6 Suppl 7):55-60. PubMed ID: 3321647
[No Abstract] [Full Text] [Related]
5. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of NK activity of HNK-1+ cells after transplantation of fetal thymus and liver or haploidentical soybean agglutinin-treated marrow cells in two severe combined immunodeficiency patients.
Gotoh YI; Yamaguchi Y; Minegishi M; Konno T; Tada K
Clin Exp Immunol; 1985 Sep; 61(3):608-13. PubMed ID: 3907904
[TBL] [Abstract][Full Text] [Related]
7. Interleukin 2 induces human acute lymphocytic leukemia cells to manifest lymphokine-activated-killer (LAK) cytotoxicity.
Kaufmann Y; Levanon M; Davidsohn J; Ramot B
J Immunol; 1987 Aug; 139(3):977-82. PubMed ID: 3496395
[TBL] [Abstract][Full Text] [Related]
8. Graft failures after T cell depleted marrow transplants for leukemia: clinical and in vitro characteristics.
Kernan NA; Bordignon C; Keever CA; Cunningham I; Castro-Malaspina H; Collins NH; Small TN; Brochstein J; Emanuel D; Laver J
Transplant Proc; 1987 Dec; 19(6 Suppl 7):29-32. PubMed ID: 2962353
[No Abstract] [Full Text] [Related]
9. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two immuno-mechanical methods of T-cell depletion of human bone-marrow for prevention of graft-versus-host disease: soybean lectin agglutination and sheep erythrocyte rosette depletion versus triple rosette depletion.
Woolfrey AE; Neudorf S; Filipovich AH
Thymus; 1985; 7(6):327-34. PubMed ID: 3909540
[TBL] [Abstract][Full Text] [Related]
11. Generation of T cell blasts with NK-like activity in human MLC: cellular precursors, IL 2 responsiveness, and phenotype expression.
López-Botet M; Silva A; Rodríguez J; de Landazuri MO
J Immunol; 1982 Sep; 129(3):1109-15. PubMed ID: 6213707
[No Abstract] [Full Text] [Related]
12. Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium.
Timonen T; Ortaldo JR; Vose BM; Henkart M; Alvarez J; Herberman RB
J Reticuloendothel Soc; 1983 Jan; 33(1):67-80. PubMed ID: 6601190
[No Abstract] [Full Text] [Related]
13. Characterization of natural killer (NK) cells and killer (K) cells in human blood: discrimination between NK and K cell activities.
Bolhuis RL; Schuit HR; Nooyen AM; Ronteltap CP
Eur J Immunol; 1978 Oct; 8(10):731-40. PubMed ID: 309395
[No Abstract] [Full Text] [Related]
14. New technology for the depletion of T cells from soybean lectin agglutinated, HLA-matched bone marrow grafts for leukemia: initial laboratory and clinical results.
Collins NH; Carabasi MH; Bleau S; Jagiello C; Young JW; Castro-Malaspina H; Flomenberg N; Papadopoulos EB; Emanuel D; Gillio A
Prog Clin Biol Res; 1992; 377():427-39. PubMed ID: 1438441
[No Abstract] [Full Text] [Related]
15. Differential expression of lymphokine-activated killer cells and natural killer cells in adoptive transfer experiments utilizing fractionated bone marrow.
Merluzzi VJ; Trail PA; Last-Barney K
J Immunol; 1986 Oct; 137(8):2425-7. PubMed ID: 3531332
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of NK cell activity by IL-2.
Herberman RB
Prog Clin Biol Res; 1987; 244():267-74. PubMed ID: 3498952
[No Abstract] [Full Text] [Related]
17. Differentiation of NK-like cells from OKT3-, OKT11+, and OKM1+ small resting lymphocytes by culture with autologous T cell blasts and lymphokine.
Warren HS
J Immunol; 1984 Jun; 132(6):2888-94. PubMed ID: 6233364
[TBL] [Abstract][Full Text] [Related]
18. Characterization of HNK-1+ (Leu-7) human lymphocytes. I. Two distinct phenotypes of human NK cells with different cytotoxic capability.
Abo T; Cooper MD; Balch CM
J Immunol; 1982 Oct; 129(4):1752-7. PubMed ID: 6980948
[TBL] [Abstract][Full Text] [Related]
19. Excessive vulnerability of herpes-infected endothelium to lymphokine-activated lymphocytes: a possible role in lethal viral pneumonitis following bone marrow transplantation.
Vercellotti GM; Kotasek D; Jacob HS
Trans Assoc Am Physicians; 1988; 101():310-3. PubMed ID: 2855899
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and functional reconstitution of peripheral blood lymphocytes following T cell-depleted bone marrow transplantation from partially mismatched related donors.
Lamb LS; Gee AP; Henslee-Downey PJ; Geier SS; Hazlett L; Pati AR; Godder K; Abhyankar SA; Turner MW; Lee C; Harris WG; Parrish RS
Bone Marrow Transplant; 1998 Mar; 21(5):461-71. PubMed ID: 9535038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
